Company Overview
Snapshot
Founded in November 2024 by Shirel Attia, SleepAI operates with 1–10 employees. The company has raised $820,000 across one funding round from one investor. In May 2025, the company announced the clinical validation of its AI algorithms for diagnosing obstructive sleep apnea and sleep staging from oximetry and photoplethysmography.
Business overview
SleepAI develops an AI-based medical monitoring system for the accurate, accessible, and scalable detection of obstructive sleep apnea (OSA) and other sleep disorders. The core technology leverages oximetry signal analysis to identify OSA severity with clinical-grade accuracy comparable to polysomnography (PSG). This solution enables non-invasive, multi-night, at-home or in-hospital diagnosis, sleep stage classification, and continuous patient monitoring. SleepAI targets the digital healthcare market, specifically patient remote monitoring, serving healthcare providers, insurance companies, and the medical equipment industry.
Strategic signal
In May 2025, SleepAI announced the clinical validation of its AI algorithms for diagnosing adult obstructive sleep apnea and sleep staging using oximetry and photoplethysmography. This validation, published in a peer-reviewed journal, signals significant progress in bringing a clinically robust and scalable solution to market, addressing a critical gap in sleep disorder detection and management and indicating strong potential for commercial adoption and improved patient outcomes.
Log in to access full profile ›Company Intelligence Q&A
- When was SleepAI founded and by whom?
- SleepAI was founded in November 2024 by Shirel Attia.
- What is SleepAI's primary focus in the healthcare sector?
- SleepAI focuses on developing an AI-based medical monitoring system for the accurate and accessible detection of obstructive sleep apnea (OSA) and other sleep disorders, utilizing oximetry signal analysis.
- What was a significant recent development for SleepAI regarding its technology?
- In May 2025, SleepAI announced the clinical validation of its artificial intelligence algorithms for the diagnosis of adult obstructive sleep apnea and sleep staging from oximetry and photoplethysmography.
- What is the total capital raised by SleepAI?
- SleepAI has raised a total of $820,000 across one funding round.